[
    {
        "content": "* Qtrly net revenue increased 4.8% to $440 million compared to same quarter last year\u200b",
        "date": "10262017",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Icon Plc Q3 EPS $1.35 "
    },
    {
        "content": "* Qtrly \u200dnet revenue increased 5.0% to $431 million; qtrly earnings per share $1.31\u200b",
        "date": "07272017",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Icon sees \u200d2017 earnings per share $5.18-$5.38 "
    },
    {
        "content": "* Icon Plc - has acquired Mapi Group Source text for Eikon: Further company coverage:",
        "date": "07272017",
        "name": "ICON plc",
        "news_type": "normal",
        "symbol": "ICLR",
        "title": "BRIEF-Icon acquires Mapi Group "
    },
    {
        "content": "* Q4 earnings per share view $1.26 -- Thomson Reuters I/B/E/S",
        "date": "02162017",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Icon reports Q4 earnings of $1.33 per share "
    },
    {
        "content": "* Co confirmed its current guidance  of 2016 earnings in range of $4.60 - $4.80 and 2016 revenue in range of $1 665 - $1 680 million",
        "date": "01092017",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Icon sees FY 2017 earnings per share $5.00 to $5.20 "
    },
    {
        "content": "* Cynosure receives CFDA clearance to market the Icon aesthetic system in China",
        "date": "11292016",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Cynosure receives CFDA nod to market the Icon aesthetic system in China "
    },
    {
        "content": "* Icon announces appointment of Ronan Murphy to board of directors  Source text for Eikon:  Further company coverage:",
        "date": "10242016",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-Icon announces appointment of Ronan Murphy to board "
    },
    {
        "content": "* Q3 earnings per share view $1.18 -- Thomson Reuters I/B/E/S",
        "date": "10202016",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-ICON Q3 earnings per share $1.19 excluding items "
    },
    {
        "content": "WELLINGTON  July 1 Australian cancer treatment provider Icon Group said it expects its biggest investor  private equity firm Quadrant  to sell its 55 percent stake in an initial public offering by mid-2017  and said Icon is now worth A$1 billion ($745 million) in total.",
        "date": "07012016",
        "name": "ICON plc",
        "news_type": "normal",
        "symbol": "ICLR",
        "title": "Australia's Icon Group expects majority owner Quadrant to seek IPO by mid-2017 "
    },
    {
        "content": "* Pfizer has right to extend term for up to an additional two years.",
        "date": "06102016",
        "name": "ICON plc",
        "news_type": "topStory",
        "symbol": "ICLR",
        "title": "BRIEF-ICON signed new three-year agreement with Pfizer Inc. "
    },
    {
        "content": "* Icon plc says  Pfizer has right to extend term for up to an additional two years",
        "date": "06102016",
        "name": "ICON plc",
        "news_type": "normal",
        "symbol": "ICLR",
        "title": "BRIEF-Icon announces service agreement with Pfizer "
    }
]